179 related articles for article (PubMed ID: 38217023)
1. Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators.
Su X; Liang C; Chen R; Duan S
Mol Cancer; 2024 Jan; 23(1):13. PubMed ID: 38217023
[TBL] [Abstract][Full Text] [Related]
2.
Bill R; Wirapati P; Messemaker M; Roh W; Zitti B; Duval F; Kiss M; Park JC; Saal TM; Hoelzl J; Tarussio D; Benedetti F; Tissot S; Kandalaft L; Varrone M; Ciriello G; McKee TA; Monnier Y; Mermod M; Blaum EM; Gushterova I; Gonye ALK; Hacohen N; Getz G; Mempel TR; Klein AM; Weissleder R; Faquin WC; Sadow PM; Lin D; Pai SI; Sade-Feldman M; Pittet MJ
Science; 2023 Aug; 381(6657):515-524. PubMed ID: 37535729
[TBL] [Abstract][Full Text] [Related]
3. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8
Luan X; Lei T; Fang J; Liu X; Fu H; Li Y; Chu W; Jiang P; Tong C; Qi H; Fu Y
Mol Ther; 2024 Feb; 32(2):469-489. PubMed ID: 38098230
[TBL] [Abstract][Full Text] [Related]
4. SPP1
Wu J; Shen Y; Zeng G; Liang Y; Liao G
Cancer Gene Ther; 2024 Feb; 31(2):311-321. PubMed ID: 38052857
[TBL] [Abstract][Full Text] [Related]
5. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
Li X; Zhang Q; Chen G; Luo D
Front Immunol; 2021; 12():694801. PubMed ID: 34295336
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages.
Xu L; Chen Y; Liu L; Hu X; He C; Zhou Y; Ding X; Luo M; Yan J; Liu Q; Li H; Lai D; Zou Z
PLoS Genet; 2024 Apr; 20(4):e1011235. PubMed ID: 38648200
[TBL] [Abstract][Full Text] [Related]
7. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
Liu Y; Xun Z; Ma K; Liang S; Li X; Zhou S; Sun L; Liu Y; Du Y; Guo X; Cui T; Zhou H; Wang J; Yin D; Song R; Zhang S; Cai W; Meng F; Guo H; Zhang B; Yang D; Bao R; Hu Q; Wang J; Ye Y; Liu L
J Hepatol; 2023 Apr; 78(4):770-782. PubMed ID: 36708811
[TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and Fibroblasts.
Sathe A; Mason K; Grimes SM; Zhou Z; Lau BT; Bai X; Su A; Tan X; Lee H; Suarez CJ; Nguyen Q; Poultsides G; Zhang NR; Ji HP
Clin Cancer Res; 2023 Jan; 29(1):244-260. PubMed ID: 36239989
[TBL] [Abstract][Full Text] [Related]
9. Characterizing Intercellular Communication of Pan-Cancer Reveals SPP1+ Tumor-Associated Macrophage Expanded in Hypoxia and Promoting Cancer Malignancy Through Single-Cell RNA-Seq Data.
Wei J; Chen Z; Hu M; He Z; Jiang D; Long J; Du H
Front Cell Dev Biol; 2021; 9():749210. PubMed ID: 34676217
[TBL] [Abstract][Full Text] [Related]
10. Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis.
Zhang Q; Liu Y; Wang X; Zhang C; Hou M; Liu Y
Front Immunol; 2023; 14():1184167. PubMed ID: 37675100
[TBL] [Abstract][Full Text] [Related]
11. Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma.
Wu Y; Ren L; Tang Y; Zhu Z; Liu S; Jiang Y; Zhang S; Zhuang X; Chen Y
Aging (Albany NY); 2023 Oct; 15(20):11588-11610. PubMed ID: 37889539
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor Phenotype.
Enbergs N; Halabi EA; Goubet AG; Schleyer K; Fredrich IR; Kohler RH; Garris CS; Pittet MJ; Weissleder R
Adv Sci (Weinh); 2024 Apr; 11(15):e2309026. PubMed ID: 38342608
[TBL] [Abstract][Full Text] [Related]
13. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
14. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
Marcovecchio PM; Thomas G; Salek-Ardakani S
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637602
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
16. The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages.
Matsubara E; Yano H; Pan C; Komohara Y; Fujiwara Y; Zhao S; Shinchi Y; Kurotaki D; Suzuki M
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190178
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes.
Yang Q; Zhang H; Wei T; Lin A; Sun Y; Luo P; Zhang J
Front Immunol; 2021; 12():756722. PubMed ID: 34804043
[TBL] [Abstract][Full Text] [Related]
18. Macrophage barrier in the tumor microenvironment and potential clinical applications.
Ji S; Shi Y; Yin B
Cell Commun Signal; 2024 Jan; 22(1):74. PubMed ID: 38279145
[TBL] [Abstract][Full Text] [Related]
19. M1
Garrido-Martin EM; Mellows TWP; Clarke J; Ganesan AP; Wood O; Cazaly A; Seumois G; Chee SJ; Alzetani A; King EV; Hedrick CC; Thomas G; Friedmann PS; Ottensmeier CH; Vijayanand P; Sanchez-Elsner T
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699181
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer.
Liu X; Qin J; Nie J; Gao R; Hu S; Sun H; Wang S; Pan Y
Front Immunol; 2023; 14():1185208. PubMed ID: 37691929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]